NEWS RELEASE

Department of Defense
United States Army Medical Research and Development Command
Congressionally Directed Medical Research Programs

Released: December 24, 2019

CDMRP Research Funding for 2020

The Fiscal Year 2020 Department of Defense Appropriations Act provides research funding for the following peer reviewed programs managed by the Department of Defense office of Congressionally Directed Medical Research Programs (CDMRP):

• Amyotrophic Lateral Sclerosis Research Program - $20.0 million
• Autism Research Program - $15.0 million
• Bone Marrow Failure Research Program - $3.0 million
• Breast Cancer Research Program - $150.0 million
• Chronic Pain Management Research Program - $15.0 million
• Combat Readiness Medical Research Program - $10.0 million
• Duchenne Muscular Dystrophy Research Program - $10.0 million
• Epilepsy Research Program - $12.0 million
• Gulf War Illness Research Program - $22.0 million
• Hearing Restoration Research Program – $10.0 million
• Kidney Cancer Research Program - $40.0 million
• Joint Warfighter Medical Research Program - $40.0 million
• Lung Cancer Research Program – $14.0 million
• Lupus Research Program - $10.0 million
• Melanoma Research Program - $20.0 million
• Military Burn Research Program – $10.0 million
• Multiple Sclerosis Research Program - $16.0 million
• Neurofibromatosis Research Program - $15.0 million
• Neurotoxin Exposure Treatment Parkinson's - $16.0 million
• Orthotics and Prosthetics Outcomes Research Program- $15.0 million
• Ovarian Cancer Research Program - $35.0 million
• Pancreatic Cancer Research Program - $6.0 million  (new for FY 20)
• Peer Reviewed Alzheimer's Research Program – $15.0 million
• Peer Reviewed Cancer Research Program (14 Topics) - $110 million
• Peer Reviewed Medical Research Program (44 Topics) - $360 million
• Peer Reviewed Orthopaedic Research Program - $30 million
• Prostate Cancer Research Program - $110 million
• Rare Cancers Research Program - $7.5 million  (new for FY 20)
• Reconstructive Transplant Research Program - $12.0 million
• Scleroderma Research Program - $5.0 million (new for FY 20)
• Spinal Cord Injury Research Program - $40.0 million
• Tick-Borne Disease Research Program - $7.0 million
• Tuberous Sclerosis Complex Research Program - $6.0 million
• Vision Research Program - $20.0 million

Pre-announcements and comprehensive Program Announcements will be forthcoming. The pre-announcements will provide a general overview of the anticipated funding mechanisms. The Program Announcements will include detailed descriptions of funding mechanisms, evaluation criteria, submission requirements, and deadlines. Each Program Announcement may be downloaded from the Grants.gov website http://www.grants.gov, or the CDMRP website https://CDMRP.HEALTH.MIL upon its release.

For email notification when pre-announcements and Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org.

For more information about the CDMRP, our research programs, previous awardees, as well as research highlights and videos, please visit the website at https://CDMRP.HEALTH.MIL.

Point of Contact:

CDMRP Public Affairs
301-619-7783
usarmy.detrick.medcom-cdmrp.mbx.cdmrp-public-affairs@mail.mil